Key result
Local renin-angiotensin systems have speculative clinical relevance, as much of the evidence for novel RAS components is based on animal studies rather than clinical trials.
Key points are not available for this paper at this time.
Clinical adoption of local RAS targets remains premature; leaves open their role pending human trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Duncan J. Campbell (2014) reported an editorial. Local renin-angiotensin systems have speculative clinical relevance, as much of the evidence for novel RAS components is based on animal studies rather than clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: